Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18369625rdf:typepubmed:Citationlld:pubmed
pubmed-article:18369625lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18369625lifeskim:mentionsumls-concept:C0038013lld:lifeskim
pubmed-article:18369625lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:18369625lifeskim:mentionsumls-concept:C1367028lld:lifeskim
pubmed-article:18369625lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:18369625lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:18369625pubmed:issue10lld:pubmed
pubmed-article:18369625pubmed:dateCreated2008-7-11lld:pubmed
pubmed-article:18369625pubmed:abstractTextAnkylosing spondylitis (AS) is characterized by ankylosis of axial joints but osteoporosis is also a well-reported feature. T cells have been implicated as a source of receptor activator of NFkappaB ligand (RANKL) in inflammatory bone diseases. Hence, we assessed whether T cells in patients with AS act as a source of RANKL too. Therefore, we investigated the expression of RANKL on T cells from 21 patients with AS by flow cytometry. Bone mineral density (BMD) was evaluated by quantitative computer tomography (QCT) and dual X-ray absorptiometry (DXA) and correlated with serum levels of osteoprotegerin (OPG) and RANKL. BMD was decreased in 45% of all patients when measured with DXA (48% with QCT) and correlated negatively with OPG. Expression of intracellular RANKL was increased on CD4+ (84 vs. 70%) and CD8+ (85.2 vs. 65.3%, P < 0.05) T cells in patients with AS, whereas expression of membrane-bound RANKL was significantly lower (CD4+: 2.2 vs. 8.5% and CD8+: 0.7 vs. 3.2%, P < 0.01). Our results indicate that surface and intracellular RANKL production is differentially regulated on T cells of patients with AS.lld:pubmed
pubmed-article:18369625pubmed:languageenglld:pubmed
pubmed-article:18369625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18369625pubmed:citationSubsetIMlld:pubmed
pubmed-article:18369625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18369625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18369625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18369625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18369625pubmed:statusMEDLINElld:pubmed
pubmed-article:18369625pubmed:monthAuglld:pubmed
pubmed-article:18369625pubmed:issn0172-8172lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:PietschmannPe...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:ReschHeinrich...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:RaunerMartina...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:MuschitzChris...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:PatschJaninaJlld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:StupphannDani...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:KrenbekDagmar...lld:pubmed
pubmed-article:18369625pubmed:authorpubmed-author:PirkerThomasTlld:pubmed
pubmed-article:18369625pubmed:issnTypePrintlld:pubmed
pubmed-article:18369625pubmed:volume28lld:pubmed
pubmed-article:18369625pubmed:ownerNLMlld:pubmed
pubmed-article:18369625pubmed:authorsCompleteYlld:pubmed
pubmed-article:18369625pubmed:pagination987-93lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:meshHeadingpubmed-meshheading:18369625...lld:pubmed
pubmed-article:18369625pubmed:year2008lld:pubmed
pubmed-article:18369625pubmed:articleTitleIntracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis.lld:pubmed
pubmed-article:18369625pubmed:affiliationDepartment of Pathophysiology, Center of Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria. daniela.stupphann@meduniwien.ac.atlld:pubmed
pubmed-article:18369625pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:8600entrezgene:pubmedpubmed-article:18369625lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18369625lld:entrezgene
lhgdn:association:2687lhgdn:found_inpubmed-article:18369625lld:lhgdn